G13C (p.Gly13Cys) variant of KRAS (GTPase KRas)

G13C (p.Gly13Cys) in KRAS (GTPase KRas) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic/likely pathogenic in the context of KRAS-related disorder; not provided; Non-small cell lung carcinoma. The available variant effect predictions contribute to a CATVariant prioritization score of 0.70 / 1. The record also includes experimental measurements, published literature, and structural context.

G13C (p.Gly13Cys) variant details